Literature DB >> 34240245

Diastolic Dysfunction Contributes to Impaired Cardiorespiratory Fitness in Patients with Lung Cancer and Reduced Lung Function Following Chest Radiation.

Georgia K Thomas1, Cory R Trankle2, Salvatore Carbone2,3, Hayley Billingsley2,3, Benjamin W Van Tassell2,4, Ronald K Evans3, Ryan Garten3, Elisabeth Weiss5, Antonio Abbate2,6, Justin M Canada2.   

Abstract

Cardiorespiratory fitness (CRF) is a robust and independent predictor of cardiovascular health and overall mortality. Patients with lung cancer often have chronic lung disease, contributing to impaired CRF. Radiation to the heart during lung cancer treatment may further reduce CRF. The determinants of CRF in this population are not well understood. We prospectively evaluated 12 patients with lung cancer without known cardiovascular disease with reduced lung function receiving curative intent thoracic radiotherapy to determine whether cardiac diastolic function, as assessed by Doppler echocardiography and N-terminal pro-brain natriuretic peptide (NTproBNP) levels, correlate with CRF measured by peak oxygen consumption (VO2). Doppler-derived measures of diastolic function and serum NTproBNP levels inversely correlated with peak VO2. In a multivariate regression model, NTproBNP was the strongest independent variable associated with peak VO2. These results suggest that diastolic dysfunction further contributes to reduced CRF in patients with lung cancer who have received radiotherapy.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cardiorespiratory fitness; Lung cancer; N-terminal pro-brain natriuretic peptide; Radiotherapy

Mesh:

Year:  2021        PMID: 34240245      PMCID: PMC8627110          DOI: 10.1007/s00408-021-00454-6

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   3.777


  14 in total

1.  Subclinical Cardiotoxicity Associated With Cancer Therapy: Early Detection and Future Directions.

Authors:  Edward T H Yeh; Pimprapa Vejpongsa
Journal:  J Am Coll Cardiol       Date:  2015-06-16       Impact factor: 24.094

2.  Determinants of Cardiorespiratory Fitness Following Thoracic Radiotherapy in Lung or Breast Cancer Survivors.

Authors:  Justin M Canada; Cory R Trankle; Salvatore Carbone; Leo F Buckley; Medina de Chazal; Hayley Billingsley; Ronald K Evans; Ryan Garten; Benjamin W Van Tassell; Dinesh Kadariya; Adolfo Mauro; Stefano Toldo; Eleonora Mezzaroma; Ross Arena; William G Hundley; John D Grizzard; Elisabeth Weiss; Antonio Abbate
Journal:  Am J Cardiol       Date:  2019-12-26       Impact factor: 2.778

3.  Evaluation of Natriuretic Peptide in Non-small Cell Lung Cancer Patients Treated with Bevacizumab Together with Carboplatin-Paclitaxel: A Prospective Study.

Authors:  Tomoyuki Otsuka; Takashi Nojiri; Seigo Minami; Hiroshi Hosoda; Muneyoshi Kuroyama; Haruhiko Hirata; Kaori Nakanishi; Suguru Yamamoto; Kiyoshi Komuta; Kenji Kangawa; Takashi Kijima
Journal:  Anticancer Res       Date:  2017-07       Impact factor: 2.480

4.  Peak oxygen consumption and long-term all-cause mortality in nonsmall cell lung cancer.

Authors:  Lee W Jones; Dorothy Watson; James E Herndon; Neil D Eves; Benjamin E Haithcock; Gregory Loewen; Leslie Kohman
Journal:  Cancer       Date:  2010-10-15       Impact factor: 6.860

5.  Cardiac Radiation Dose, Cardiac Disease, and Mortality in Patients With Lung Cancer.

Authors:  Katelyn M Atkins; Bhupendra Rawal; Tafadzwa L Chaunzwa; Nayan Lamba; Danielle S Bitterman; Christopher L Williams; David E Kozono; Elizabeth H Baldini; Aileen B Chen; Paul L Nguyen; Anthony V D'Amico; Anju Nohria; Udo Hoffmann; Hugo J W L Aerts; Raymond H Mak
Journal:  J Am Coll Cardiol       Date:  2019-06-18       Impact factor: 24.094

6.  Complementary roles of simple variables, NYHA and N-BNP, in indicating aerobic capacity and severity of heart failure.

Authors:  S G Williams; L L Ng; R J O'Brien; S Taylor; D J Wright; Y F Li; L B Tan
Journal:  Int J Cardiol       Date:  2005-07-10       Impact factor: 4.164

7.  Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  Alessandro Brunelli; Anthony W Kim; Kenneth I Berger; Doreen J Addrizzo-Harris
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

8.  A lower level of forced expiratory volume in one second predicts the poor prognosis of small cell lung cancer.

Authors:  Hye Seon Kang; Ah Young Shin; Chang Dong Yeo; Ju Sang Kim; Yong Hyun Kim; Jin Woo Kim; Sang Haak Lee
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

9.  Cardiac Toxicity After Radiotherapy for Stage III Non-Small-Cell Lung Cancer: Pooled Analysis of Dose-Escalation Trials Delivering 70 to 90 Gy.

Authors:  Kyle Wang; Michael J Eblan; Allison M Deal; Matthew Lipner; Timothy M Zagar; Yue Wang; Panayiotis Mavroidis; Carrie B Lee; Brian C Jensen; Julian G Rosenman; Mark A Socinski; Thomas E Stinchcombe; Lawrence B Marks
Journal:  J Clin Oncol       Date:  2017-01-23       Impact factor: 50.717

10.  Lung function parameters improve prediction of VO2peak in an elderly population: The Generation 100 study.

Authors:  Erlend Hassel; Dorthe Stensvold; Thomas Halvorsen; Ulrik Wisløff; Arnulf Langhammer; Sigurd Steinshamn
Journal:  PLoS One       Date:  2017-03-20       Impact factor: 3.240

View more
  1 in total

1.  LUNG Year in Review: 2021.

Authors:  Peter V Dicpinigaitis
Journal:  Lung       Date:  2022-01-18       Impact factor: 3.777

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.